Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-18

Clinical Trial Update: Study of Single IV Administration of P2G12 [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a single IV administration of P2G12 in HIV infection; the study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • P2G12 (P2G12 antibody)

Snippet

Sponsor: St George's, University of London | Conditions: HIV Infection | Phase 1 | Status: UNKNOWN